Aspen Pharmacare Holdings Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aspen Pharmacare Holdings Limited generated cash of $6,225,000,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,623,000,000 last year. Net change in cash is therefore -$273,000,000.
Cash Flow
| 2015 | 4.8B | -1.6B | -2.2B |
|---|---|---|---|
| 2016 | 221.31M | 76.07M | -214.39M |
| 2017 | 478.53M | -861.35M | 404.91M |
| 2018 | 545.29M | -995.70M | 492.14M |
| 2019 | 423.10M | 225.36M | -791.22M |
| 2020 | 527.21M | 103.65M | -731.78M |
| 2021 | 442.77M | 633.37M | -1.01B |
| 2022 | 353.05M | -141.97M | -307.20M |
| 2023 | 310.58M | -192.48M | -23.63M |
| 2024 | 6.22B | -9.46B | 3.62B |
APNHY Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.49B | 377.41M | 598.51M | 408.23M | 636.61M | 814.95M | 816.62M | 744.25M | 6.9B | 6.2B |
Operating activities | ||||||||||
Net income | 6.99B | 294.15M | 426.24M | 311.27M | 215.73M | 118.35M | 436.81M | 375.46M | 297.38M | 8.4B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.97B | 100.60M | 112.53M | 106.20M | 99.25M | 82.47M | 86.18M | 95.70M | 82.99M | 1B |
Stock-based compensation expense | 117M | 135M | 58M | 67M | 49M | 37M | 43M | 56M | 100M | 100M |
| Deferred income tax benefit | 117M | 135M | 58M | 67M | 49M | 37M | 43M | 56M | 100M | 100M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -104M | 18.39M | -89.01M | 22.57M | 103.27M | 61.25M | -15.93M | -198.77M | 0 | -400M |
Inventories | 200M | -151.97M | -142.43M | -18.16M | -46.40M | -72.46M | -86.80M | -80.98M | -248.97M | -1.2B |
Accounts payable | 0 | -55.36M | 57.22M | 37.62M | -44.61M | -85.93M | -21.37M | 213.49M | 13.83M | 0 |
Cash generated by operating activities | 6.22B | 310.58M | 353.05M | 442.77M | 527.21M | 423.10M | 545.29M | 478.53M | 221.31M | 4.8B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -90M | 0 | 0 | 0 | 0 | 0 | 0 | -100M |
Investments In Property Plant And Equipment | -3.11B | -178.98M | -177.18M | -222.58M | -171.69M | -252.57M | -235.15M | -213.49M | -193.64M | -2.4B |
Acquisitions Net | -911M | -17.10M | 4.99M | 819.30M | 251.03M | 377.07M | -769.25M | -692.02M | 311.22M | -2.3B |
Cash generated by investing activities | -9.46B | -192.48M | -141.97M | 633.37M | 103.65M | 225.36M | -995.70M | -861.35M | 76.07M | -1.6B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | -7.64B | 0 | 3.1B | 200K |
Payments for dividends | -1.52B | -1.45B | -1.19B | 0 | 0 | -1.43B | -1.31B | -1.23B | -1B | -900M |
Repurchases of common stock | -56M | -7.65M | -1.85B | -3.24M | -2.61M | -29M | -3.41M | -33M | -6.91M | 12.89B |
Repayments of term debt | 5.40B | 1.17B | -1.45B | -999.66M | -718.57M | -9.75B | -597.59M | 6.21B | -138.32M | -1.3B |
Cash used in financing activities | 3.62B | -23.63M | -307.20M | -1.01B | -731.78M | -791.22M | 492.14M | 404.91M | -214.39M | -2.2B |
Net Change In Cash | -273M | 200.20M | -221.09M | 190.28M | -228.38M | -178.34M | -1.66M | 72.37M | -6.15B | 700M |
Cash at end of period | 7.22B | 577.62M | 377.41M | 598.51M | 408.23M | 636.61M | 814.95M | 816.62M | 744.25M | 6.9B |